<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01954017</url>
  </required_header>
  <id_info>
    <org_study_id>STP206-002</org_study_id>
    <nct_id>NCT01954017</nct_id>
  </id_info>
  <brief_title>STP206 for the Prevention of NEC</brief_title>
  <official_title>A Phase Ib/IIa Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leadiant Biosciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Leadiant Biosciences, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will be conducted in two parts. Part A will be a sequential dose escalation study
      to determine the safety and tolerability of two doses of STP206 versus control. Part B will
      evaluate safety and NEC preventive efficacy of STP206 in VLBW and ELBW neonates.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the safety and tolerability of once daily dosing of two dose levels of STP206 versus control in four different birth weight strata in premature neonates.</measure>
    <time_frame>48 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the fecal shedding after daily dosing of each component of STP206 throughout the dosing phase</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the incidence of NEC in STP206-treated subjects compared to control</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the incidence of clinical events (sepsis/bacteremia, feeding intolerance, morbidity/complications of prematurity) in STP206-treated subjects compared to control</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the progression of standard neonatal growth parameters in STP206-treated subjects compared to control</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <arm_group>
    <arm_group_label>STP 206</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biological</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sterile Water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sterile water</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>STP 206</intervention_name>
    <description>Live Biotherapeutic</description>
    <arm_group_label>STP 206</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Sterile Water</intervention_name>
    <arm_group_label>Sterile Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Neonates with birth weights between 2000-500g for Part A and 1500-500g for Part B

          2. Ability to start treatment within four days after birth.

          3. Gestational age between 23 and 32 weeks at birth

          4. Obtaining of informed consent from the subject's mother after full understanding of
             the study purpose and procedures.

          5. Parents who agree to allow the Principal Investigator and his/her staff to follow the
             procedures and assessments required by the protocol

        Exclusion Criteria:

          1. Infants with, or at high probability for, early onset sepsis (positive blood cultures
             or with clinical/histological chorioamnionitis with the expectation of empirical
             antimicrobial therapy for â‰¥5 days)

          2. Infants with persistent pulmonary hypertension of the newborn (PPHN)

          3. Congenital or chromosomal anomalies

          4. Congenital or acquired gastrointestinal pathology that preclude feeds soon after birth
             (e.g. cleft lip is not an exclusion criterion, but a duodenal atresia is)

          5. Infants in extremis to whom no further intensive care is offered by attending
             neonatologist (e.g., infant being provided only hospice/comfort care)

          6. Other conditions of the infant which, in the opinion of the attending neonatologist,
             preclude participation

          7. Positive maternal HIV status

          8. Participation in another interventional clinical trial

             For Part A of the study, the following additional exclusion criterion will apply:

          9. Small for gestational age neonates, i.e. neonates that weigh less that the 10th
             percentile for their gestational age according to the Estimated Fetal Weight
             Percentile Chart
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael S Caplan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Falleroni</last_name>
    <phone>301-670-5447</phone>
    <email>daniel.falleroni@leadiant.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Scott Rodgers, MS, CCRA</last_name>
    <phone>301-670-1565</phone>
    <email>scott.rodgers@leadiant.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Querim</last_name>
      <phone>860-837-5349</phone>
      <email>jquerim@connecticutchildrens.orgdrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Kim Jennings</last_name>
      <phone>860-837-5874</phone>
      <email>kjennings@connecticutchildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Leslie Wolkoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheridan Clinical Research / Plantation General Hospital</name>
      <address>
        <city>Sunrise</city>
        <state>Florida</state>
        <zip>33323</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Pillitteri</last_name>
      <phone>954-592-8218</phone>
      <email>James.Pillitteri@shcr.com</email>
    </contact>
    <investigator>
      <last_name>Mitchell Stern, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgia Regents University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanya Mims</last_name>
      <phone>706-721-9680</phone>
      <email>tamims@gru.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nancy Starnes</last_name>
      <phone>706-721-9680</phone>
      <email>nstarnes@gru.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jatinder Bhatia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilene Sue Wolf, RNC CCRP</last_name>
      <phone>847-570-2045</phone>
      <email>iwolf@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Brandy L Frost, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Illinois University School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62769</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Spenner</last_name>
      <phone>217-545-9714</phone>
      <email>aspenner@siumed.edu</email>
    </contact>
    <contact_backup>
      <last_name>Carol Peterson</last_name>
      <phone>217-545-5061</phone>
      <email>cpeterson@siumed.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Beau Batton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wesley Medical Center</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Delmore, MSN</last_name>
      <phone>316-962-8555</phone>
    </contact>
    <investigator>
      <last_name>Barry T Bloom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neha Thakkar</last_name>
      <phone>617-667-8776</phone>
      <email>npthakka@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Ivan Frantz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Klein</last_name>
      <phone>413-599-0226</phone>
      <email>deborah.klein@baystatehealth.org</email>
    </contact>
    <investigator>
      <last_name>Rachana Singh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WakeMed Health and Hospitals</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ginger Rhodes-Ryan, MSN, NNP-BC</last_name>
      <phone>919-350-7026</phone>
      <email>grhodes-ryan@wakemed.org</email>
    </contact>
    <investigator>
      <last_name>Stephen Kicklighter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenreka Yeardon</last_name>
      <phone>843-876-1471</phone>
      <email>yeardon@musc.com</email>
    </contact>
    <investigator>
      <last_name>Sarah Taylor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Jean Grimes</last_name>
      <phone>901-448-1823</phone>
      <email>sgrimes@uthsc.edu</email>
    </contact>
    <investigator>
      <last_name>Ramasubbareddy Dhanireddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Medical Center of Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Kelly</last_name>
      <phone>954-838-2479</phone>
      <email>Melanie.Kelly@shcr.com</email>
    </contact>
    <investigator>
      <last_name>Jenitha Jeyaraj, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Collins, RN</last_name>
      <phone>304-293-7348</phone>
      <email>scollins@hsc.wvu.edu</email>
    </contact>
    <investigator>
      <last_name>Autumn Kiefer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2013</study_first_submitted>
  <study_first_submitted_qc>September 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2013</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

